Aurora's Sunrise workstation gets FDA clearance
This article was originally published in Clinica
Executive Summary
Aurora Technology has received 510(k) clearance from the FDA to market its Sunrise diagnostic workstation in the US. The workstation is an imaging system designed specifically for high-volume review of radiological images. It has high-speed compression and zoom capabilities based on technology developed for the University of Chicago Hospitals and can review both scanned X-ray film and computed radiographs.
You may also be interested in...
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.